Question special
Consultants/ Senior Lecturer

Really impressive study. Just a quick question. In the control arm, why did you decide to use a placebo rather than another active vaccine that might have given some benefit to participants in the trial? Would be great to get your thoughts on this issue as both approaches are used in vaccine trials.